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Abstract 
This paper describes the development and evaluation of a RP-HPLC and UV spectrophotometric methods to 
quantify Orphenadrine Citrate and Diclofenac Sodium in Tablets and Injections. RP-HPLC analysis were carried 
out using a C18 Knauer column and a mobile phase composed of  (1% Triethylamine aqueous buffer  adjust pH=2 
by H3PO4 85%: Methanol: Acetonitrile) ; (35: 20: 45) v/v%, with a flow rate of 2.0 mL/min and UV detection at 
195 nm. For the spectrophotometric analysis, (Ultra pure water: Methanol) ; (50: 50) v/v% was used as solvent 
and the wavelength of 264, 277 nm was selected for  Orphenadrine Citrate and Diclofenac Sodium, respectively 
the detection. Both methods were found to quantify Orphenadrine Citrate and Diclofenac Sodium in Tablets and 
Injection accurately. Therefore RP-HPLC and UV methods presented the most reliable results for the analyses of 
Tablets and Injection. 
Keywords: Orphenadrine Citrate; Diclofenac Sodium; UV spectrophotometry; RP-HPLC; pharmaceutical 
formulations. 
 
1. INTRODUCTION 
Orphenadrine Citrate (OC), "IUPAC" chemically known as N,N-dimethyl-2[(2-methylphenyl)-
phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3tricarboxylic acid (Figure 1). Diclofenac Sodium 
(DS),"IUPAC" chemically known as Sodium; 2-[2-(2,6-dicloroanilino) phenyl]acetate (Figure 2).  OC was one of 
the sparingly soluble in water-soluble that is a tasteless and odorless whiteness crystal Powder [1]. OC has been 
identified as one of the most important Anticholinergic. Orphenadrine was used to treat acute muscle aches or 
spasms\pains. It was usually combined with rest, physical therapy, and other treatment [2]. DS was one of the 
water-soluble that is a tasteless and odorless whiteness crystal Powder [1]. Ds was used to relieve pain, swelling 
(inflammation), and joint stiffness caused by arthritis. Reducing these symptoms helps you do more of your normal 
daily activities. This medication is known as a non-steroidal anti-inflammatory drug (NSAID) [2]. 
  
Figure 1. Chemical structure of Orphenadrine Citrate. 
 
Figure 2. Chemical structure of Diclofenac Sodium. 
Different methods have been developed for the determination of OC in pharmaceutical formulation  
including  colorimetric  [3],  spectrophotometry [4],  capillary electrophoresis  [5],  Gas Chromatography [6]. The 
determination of DS in pharmaceutical formulation  including  colorimetric  [7],  spectrophotometry [8],  capillary 
electrophoresis  [9],  Flow injection [10] Spectrofluorsence [11-12] Voltametery [13], RP-HPLC [14]. 
 
2. EXPERIMENTAL 
2.1. Instruments and analytical conditions 
All HPLC measurements were made on a Waters 1525 Binary HPLC Pump, consisting of a 7725i manual injector 
with a 20 µL loop, integrated UV-Vis detector (Milford, MA). The system employed a 250 mm × 4.6 mm C18 
column Wat 054275 (Milford, MA) and particle size of 5 µm guard column. The detector was utilized at 195 nm 
and UV spectra from 200 to 400 nm were recorded on line for peak identification. The mobile phase consisted of 
(Triethylamine 1% buffer :Methanol: Acetonitrile) ; (35: 20: 45) v/v%, at flow rate of 2.0 mL/min. The injection 
volume was 20µL. A Jasco V–630 UV–Vis spectrophotometer with 1 cm quartz cells was used for all absorbance 
measurements under the following operating conditions: Scan speed medium (400 nm/min), scan range 200–1100 
nm and slit width 2 nm. Spectra were automatically obtained by Jasco system software. pH measurements were 
made with ORION 250A (USA) with combined glass pH electrode. 
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2.2.  Solvents and materials 
All chemicals and reagents were of analytical or pharmaceutical grade and solutions were prepared with (Methanol : 
Ultra pure Water) ; (50: 50)v/v% and Ultra pure water for more dilutions. Orphenadrine Citrate and Diclofenac 
Sodium were obtained from Aurobindo (India). The purity of OC and DS were 98.0% and 99.9% according to BP 
[1]. Methanol; Acetonitrile (HPLC grade) were obtained from Merck. Triethylamine was obtained from Sigma 
Aldrich. Pharmaceutical preparations containing OC and DS were purchased from commercial sources in the local 
market.  
 
2.3.  Preparation of Standard and Sample Solutions 
The standard stock solutions were prepared by dissolving 10 mg of Orphenadrine Citrate and Diclofenac Sodium 
reference standard, respectively in 10 mL of Methanol: Ultra pure water (50: 50 v/v%) to get a concentration of 1 
mg/mL. An aliquot of 100 µL of the obtained solution was transferred to a 10 mL volumetric flask. The final 
volume was adjusted with Ultra pure water for spectrophotometric and  chromatographic analysis, resulting in 
solutions of 10 µg/mL. 
The sample solutions were prepared by dissolving 10 mg of Orphenadrine Citrate and Diclofenac Sodium 
powder for Tablets or Injections  in 10 mL of water to get a concentration of 1 mg/mL. An aliquot of 100 µL of 
this solution was transferred to a 10 mL volumetric flask. The final volume was adjusted with water for 
spectrophotometric analysis and chromatographic analysis, to obtain a solution at 10µg/mL of Orphenadrine 
Citrate and Diclofenac Sodium. 
 
2.4.  Procedure for pharmaceutical formulations 
Twenty Tablets and Injections contents were powdered and mixed thoroughly for DC Formulation Pharmaceuticals. 
An amount corresponding to 10 mg of  DC was weighted, and OC was weighted Powder and mixed thoroughly 
for OC Formulation Pharmaceuticals, dissolved with 0.2 mL of (Methanol: Ultra pure Water) (50: 50)v/v% solution 
and diluting to 100 mL with the Ultra pure water. The volumetric flask was sonicated for 10 min. The solution was 
filtered through a Whatman filter paper (No. 1) and the resulting solution was used for analysis by the 
recommended procedures in the concentration range. 
 
3. RESULTS AND DISCUSSION 
During the chromatographic method development, Ultra pure Water showed to be a more adequate Organic solvent 
than Methanol, regarding the Orphenadrine citrate and Diclofenac sodium retention.  
After the evaluation of the Orphenadrine citrate and Diclofenac sodium UV spectrum in various solvents: 
Methanol (100%), (Ultra pure Water: Methanol) (50:50)v/v%, (Figure 3, 4), the wavelength of 264, 276 nm was 
chosen due to the adequate molar absorptivity of Orphenadrine citrate and Diclofenac sodium, respectively in this 
region and to minimize possible interference from other compounds and solvents in the samples. 
 
 
Figure 3. Chemical structure of Orphenadrine Citrate Figure 4. Chemical structure of Diclofenac sodium 
 
3.1. Validation 
A linear relationship was found between the Orphenadrine citrate and Diclofenac sodium concentrations and the 
response of both UV and HPLC methods. The regression analysis data are presented in (Table 1, 2). High 
regression coefficient (r2) values were obtained (0.9983 and 0.9997) for OC (0.9994 and 0.9999) for DS, 
respectively. A random pattern of the regression residues was found and no significant deviation of linearity was 
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detected in the assayed range. 
 
3.2. Linearity 
Standard solutions containing 1000 µg/mL of Orphenadrine citrate and Diclofenac sodium in (Methanol: Ultra 
pure water); (50:50)v/v% were prepared, in triplicate. Aliquots of these solutions were diluted in water. Seven and 
Six different concentrations, corresponding to 0.5, 1.0, 5.0, 10.0, 15.0, 20.0 and 25.0µg/mL of Diclofenac Sodium 
and to 10.0, 25.0, 50.0, 100.0, 150.0 and 200.0µg/mL (Figure 5)  Orphenadrine Citrate (for UV analysis) (Figure 
6) and eight different concentrations, corresponding to 0.10, 0.50, 1.0, 5.0, 10.0, 20.0, 40.0, and 80.0µg/mL of 
Orphenadrine citrate and Diclofenac sodium (for HPLC analysis) (Figure 7). Calibration curves with 
concentration versus peak area (Figure 7A, 7B) for OC, Ds, respectively. Or absorbance were plotted for each 
method (Figure 5A, 6A) for DS, OC, respectively. And the obtained data were subjected to regression analysis 
using the least squares method (Table 1, 2). 
 
Figure 6. Overlay standards series of  Orphenadrine 
Citrate 
Figure 5. Overlay standards series of  Diclofenac 
sodium 
 
 
 
Figure 6A. Overlay standards series of  
Orphenadrine Citrate 
Figure 5A. Overlay standards series of  Diclofenac 
Sodium 
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Figure 7. Overlay standards series of Orphenadrine Citrate and diclofenac Sodium 
 
 
 
  
Table 1. Overview of the Linearity Data Obtained for of Orphenadrine citrate by the Chromatographic and 
Spectrophotometric  Methods 
Parameter HPLC UV 
Regression coefficient (r2) 0.9997 0.9983 
Slope 115.2 658.56 
Intercept 73.247 11.939 
Concentration range (µg/mL) 0.1-80.0 10.0–200.0 
Number of points 8 6 
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Table 2. Overview of the Linearity Data Obtained for of Diclofenac Sodium by the Chromatographic and 
Spectrophotometric  Methods 
Parameter HPLC UV 
Regression coefficient (r2) 0.9999 0.9994 
Slope 116.02 31.035 
Intercept 83.788 0.0127 
Concentration range (µg/mL) 0.1-80.0 0.50–25.0 
Number of points 8 7 
 
3.3. Precision 
The methods were found to be precise as the RSD (%) values for the precision studies were well below 2% (n=3). 
The results are shown in (Table. 3). 
 
3.4. Accuracy 
The accuracy of the developed methods was found out by the standard addition method. High recovery values 
suggest that all three methods are accurate. The results are shown in (Table. 3). 
Table 3. Validation Paramaters of the Evaluated Chromatography and Spectrophotometric Methods for 
Diclofenac Sodium Determination 
Method Parameter Accuracy 
(Recovery %) 
*Precision 
(RSD %) 
LOD, 
µg/ml 
LOQ, 
µg/ml 
 
UV 
Orphenadrine Citrate (OC) 102.57% 0.92 9.61 10.04 
Diclofenac Sodium (DS) 100.57% 0.86 0.45 0.57 
 
HPLC 
Orphenadrine Citrate (OC) 100.17% 0.39 0.09 0.18 
Diclofenac Sodium (DS) 99.27% 0.41 0.08 0.16 
* Average of three determination at each  level 
 
3.5. Robustness 
The HPLC method was found to be robust under deliberate changes in the mobile phase flow rate (±0.1 mL/min), 
detection wavelength (±5 nm), and organic phase composition (±2%). The results of system suitability for the 
robustness study are shown in (Figure 7). For the UV spectroscopic methods, changing the slit width shows no 
significant effect on absorbance, indicating the robustness of the developed methods. No significant changes were 
obtained in the content of DS and OC during the solution stability studies by the developed methods.  
 
3.6. LOD & LOQ 
The limit of Determination (LOD= 3.3σ/s) and the limit of Quantitation (LOQ= 10 σ/s), σ- standard deviation of 
the regression line; s- Slope of calibration curve; was calculated by standard formula as given in ICH.  
 
4. Analysis of Tablets & Injections OC and DS 
The validated chromatographic and spectrophotometric methods were applied to the analysis of Orphenadrine 
citrate and Diclofenac sodium in Cross jesic, Medagesic and Voltamed, Diclon (Table 4, 5). Chromatographic 
analysis showed to be the most sensitive and selective method, and might be applied successfully for Orphenadrine 
citrate and Diclofenac sodium trace analysis and quantitation in biological matrices. We cannot discharge, However, 
the analyses time and cost. The spectrophotometric method is clearly less expensive and requires shorter analysis 
time, besides the ease of handling and lower residues generation. 
Since the use of Orphenadrine citrate and Diclofenac sodium as a potent Analgesic and Anti-Inflamatory  
drug is widespread, the development and validation of simple and reliable methods are essential to assure the 
quality of the raw materials and pharmaceutical formulations marketed nowadays. A simple method to identify 
and precisely quantify these drugs may be an important tool to avoid treatment inefficacy and development of 
resistance due to the exposition to sub therapeutic doses. 
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Table 4. Diclofenac Sodium Contents in Injectable Samples Obtained by HPLC and 
UV (n = 6) 
Diclofenac Sodium  content (%) ± S.D 
Sample                                  HPLC                    UV 
Voltamed 100mg\Tablet                     100.84 ± 0.24 104.49 ± 0.62 
Diclon 100mg\1mL                                     101.74 ± 0.36 105.99 ± 0.92 
S.D: standard deviation 
 
Table 5. Orphenadrine Citrate Contents in Injectable Samples Obtained by HPLC 
and UV (n = 6) 
Orphenadrine Citrate  content (%) ± S.D 
Sample                                  HPLC                    UV 
Medagesic  25mg\Tablet                   101.84 ± 0.14 103.69 ± 0.42 
Cross Jesic 35mg\Tablet                           101.74 ± 0.23 104.19 ± 0.82 
S.D: standard deviation 
 
Conclusion 
HPLC and UV spectrophotometry were found to be adequate methods to quantify Orphenadrine Citrate & 
Diclofenac Sodium in Tablets and Injection solutions; the chromatographic and spectrophotometric methods 
presented the most reliable results. Since these methods are fast and simple, they may be successfully applied to 
quality control analyses, with the aim of quantifying and identifying Orphenadrine Citrate and Diclofenac Sodium 
in pharmaceutical products. 
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